Bolt Biotherapeutics, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 57.09 | -100% | -2.65 | -100% |
| P/S |
|
4.75 | 33.5 | -85.81% |
|
|
| P/BV |
|
0.3321 | 4.61 | -92.8% |
|
|
| P/FCF |
|
-0.6253 | 39.66 | -101.58% |
|
|
| Ev/Ebitda |
|
-0.6304 | -19.46 | -96.76% |
|
|
| Ev/S |
|
5.95 | 22.56 | -73.63% |
|
|
| Ev/FCF |
|
-0.6718 | 45.47 | -101.48% |
|
|
| E/P |
|
-1.59 | 0.0172 | -9318.8% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-943.52 | -14.42 | 6442.85% | -5894.12 | -83.99% |
| ROE |
|
-61.38 | 9.01 | -781.18% |
|
|
| ROA |
|
-43.31 | 0.0151 | -286051.41% |
|
|
| ROIC |
|
-34.73 | 7.63 | -554.92% |
|
|
| ROS |
|
-878.58 | -26.5 | 3214.8% |
|
|
| ROCE |
|
-66.06 | 13.75 | -580.33% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.2721 | -3.73 | -92.7% | -0.2674 | +1.74% |
| Nеt Debt/Ebitda |
|
-0.1266 | -3.19 | -96.04% |
|
|
| Debt/Ratio |
|
0.1265 | 0.1777 | -28.8% |
|
|
| Debt/Equity |
|
0.1171 | 1.57 | -92.55% |
|
|
| Debt/Net Income |
|
-0.2922 | 0.8429 | -134.66% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5467 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.7368 | -100% | ||
| DSI |
|
0 | 0.2387 | -100% |
|
|
| Average dividend growth |
|
0 | 1.55 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4967 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.73 | -100% |
|
|
| Difference from average difference in sector |
|
-0.5467 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
10/10
|
3563.26 | 73.67 | 4736.79% | ||
| Growth impulse Ebitda in 5 years |
|
146.56 | 15.28 | 859.16% | ||
| Growth impulse Net Income in 5 years |
|
130.66 | -33.08 | -494.98% | ||
| Growth impulse FCF in 5 years |
|
158.26 | -6.99 | -2364.09% | ||
| Growth impulse EPS in 5 years |
|
-16.05 | -59.11 | -72.85% |
IP Score
4.68/10
